Better management of traumatic brain injury

July 19, 2012

New treatments to lessen the severity of the more than 21,000 Traumatic Brain Injury (TBI) cases that occur in Australia each year are on the horizon.

Published today in the leading neurology journal, Brain, a study led by researchers from Monash University's Australian Centre for (ACBD) revealed how inhibiting certain enzymes decreased the severity of TBI, providing a target for future treatments.

Caused by a blow to the head, often suffered during falls or road crashes, severe TBI can result in long-term disability or death. Effects can include impairments to cognitive and motor function, vision, hearing and . Additionally, the post-injury disruption to blood flow, and around the brain has been linked to debilitating diseases including Alzheimer's disease and post-traumatic epilepsy.

The study was led by Professor Robert Medcalf and Dr Maithili Sashindranath of the ACBD, who collaborated for five years with scientists at the University of Geneva in Switzerland and the University of Michigan in the United States.

Professor Medcalf said the researchers identified two enzymes, known as t-PA and MMP-3, that act together to promote following TBI.

"The enzyme t-PA, well known for its ability to remove blood clots, also has a healthy and very important role in supporting learning and in everyday life. However, previous research has shown that in TBI cases, its presence makes the injury much worse," Professor Medcalf said.

Initially, the researchers thought t-PA itself exacerbated the injury. However, a surprising finding of the study was that t-PA is not the culprit - its inhibition triggers the activation of MMP-3, the enzyme which does the damage.

"The activity of naturally occurring enyzmes is controlled by specific enzyme inhibitors," Professor Medcalf said.

"Unexpectedly, we found that the process of t-PA inactivation by one of its natural inhibitors actually contributed to brain injury, because it leads to the activation of MMP-3.

"Now we know that if we block MMP-3 with an inhibitor, we can protect the brain following TBI," Professor Medcalf said.

Co-author and international expert on TBI, Professor Jeffrey Rosenfeld, from Monash University's Department of Surgery said the results were exciting.

"We now have a new and promising therapeutic target for the treatment of human TBI, which has not, so far, been significantly improved by pharmacological intervention," Professor Rosenfeld said.

Research is continuing with the aim of bringing this finding to a point where clinical trials can evaluate this novel approach in patients with TBI.

Explore further: Risk factors predictive of psychiatric symptoms after traumatic brain injury

Related Stories

Risk factors predictive of psychiatric symptoms after traumatic brain injury

July 12, 2011
A history of psychiatric illness such as depression or anxiety before a traumatic brain injury (TBI), together with other risk factors, are strongly predictive of post-TBI psychiatric disorders, according to an article published ...

Study: New treatment for traumatic brain injury shows promise in animals

February 19, 2012
A new drug is showing promise in shielding against the harmful effects of traumatic brain injury (TBI) in rats, according to a study that was released today and will be presented at the American Academy of Neurology's 64th ...

Single traumatic brain injury may prompt long-term neurodegeneration

July 18, 2011
Years after a single traumatic brain injury (TBI), survivors still show changes in their brains. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania suggest that Alzheimer's ...

Traumatic brain injury: NIH-funded researchers will assess biomarkers for diagnosis and treatment

August 3, 2011
Biomarkers in the bloodstream could provide physicians with a quick and accurate method of assessing the severity of traumatic brain injury (TBI) and helping deliver and monitor the results of therapies, such as progesterone ...

Recommended for you

New study reveals contrasts in how groups of neurons function during decision making

July 19, 2017
By training mice to perform a sound identification task in a virtual reality maze, researchers at Harvard Medical School and the Istituto Italiano di Tecnologia (IIT) have identified striking contrasts in how groups of neurons ...

Memory takes time, researchers conclude

July 19, 2017
How short-term memories become long-term ones has frequently been explored by researchers. While a definitive answer remains elusive, New York University scientists Thomas Carew and Nikolay Kukushkin conclude that this transformation ...

Researchers identify new target for chronic pain

July 19, 2017
Proteins must be in the right place at the right time in the cell to function correctly. This is even more critical in a neuron than in other cells because of its complex tree-like structure and its function. Researchers ...

Brains are more plastic than we thought

July 19, 2017
Practice might not always make perfect, but it's essential for learning a sport or a musical instrument. It's also the basis of brain training, an approach that holds potential as a non-invasive therapy to overcome disabilities ...

Healthy heart in 20s, better brain in 40s?

July 19, 2017
Folks with heart-healthy habits in their 20s tend to have larger, healthier brains in their 40s—brains that may be better prepared to withstand the ravages of aging, a new study reports.

Individual insight into brain networks

July 19, 2017
Harvard scientists have gained new insights into how the brain networks important for thought and remembering are organized in individual people, bringing the notion of using brain scans to help personalize medical treatments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.